Clinical Professor
University of British Columbia, British Columbia, Canada
Dr. Jacqueline Saw is an Interventional Cardiologist at Vancouver General Hospital and St Paul’s Hospital, Clinical Professor of Medicine at UBC, and Program Director of the VGH Interventional Cardiology Fellowship Program. She served as the Head of VGH Cardiology Clinical Trials Research. She is an international key opinion leader in SCAD and LAA closure. She is the PI of the Canadian SCAD Study, Canadian SCAD Genetic Study, CanSCAD3000 Study, PRYME, NACAD, and SAFER-SCAD studies. She is a physician proctor for WATCHMAN and Amulet devices, the PI of multiple LAAC studies (ASAP-TOO, Canadian WATCHMAN Registry, Canadian ACP/Amulet Registry), and the Chair for the SCAI Expert Consensus Statement on Transcatheter LAAC. She was an associate editor of JACC Cardiovascular Intervention. She has authored over 350 peer-reviewed publications and is the primary editor of 3 textbooks on LAAC and carotid artery stenting.
Disclosure information not submitted.
Saturday, March 9, 2024
11:30 AM – 12:10 PM ET
Panel Discussion: Can We and Should We Skip TEE for LAA Closure? Role of CT and ICE?
Saturday, March 9, 2024
11:54 AM – 12:10 PM ET
Left Atrial Appendage Closure Forum
Saturday, March 9, 2024
1:50 PM – 5:45 PM ET
Saturday, March 9, 2024
1:50 PM – 3:33 PM ET
Live Case from MountainStar Heart Center at St. Mark's | Salt Lake City, UT
Saturday, March 9, 2024
1:50 PM – 2:37 PM ET
Novel Technologies for LAAC: How to Approach Challenging LAA Anatomy for Closure
Saturday, March 9, 2024
3:01 PM – 3:09 PM ET